Lecture 8 Flashcards
Haemostasis:
process of stopping loss of blood from blood vessels
Steps in Haemostasis:
- vasoconstriction: blood vessels narrow
- platelet activation: adhesion + aggregation (platelet plug formation)
• Initiated by damaged or irregular blood vessels
• Adhesion- Platelets adhere to damaged blood vessel
• Aggregation- stick to each other to form a plug - clotting cascade: intrinsic + extrinsic pathways (blood clotting)
- Fibrinolysis breakdown of fibrin initiated by the conversion of plasminogen to plasmin - LOOK AT LECTURE
APTT PATHWAY…………Intrinsic
• each activated factor activates the next in the series)
Initiated by contact with surface of blood vessel lining factor XII (12) is activated followed by (XI) 11 then (IX)9 using Ca then (VIII)8 using Ca and PF3 (platelet factor 3)
Contains factor XII, XI, IX, VIlI
Calcium is also needed for the activation
PT PATHWAY……Extrinsic
Thromboplastin (factor III) (comes from the skin) is released from damaged blood vessels and activates the next factor
Contains tissue factor and factor VII (7) using calcium
Common pathway
Check the lecture
Intrinsic and Extrinsic activates factor X (in common pathway)
Factors circulate in inactive forms until they are activated.
Stable Fibrin Clot
Fibrinogen (I) Fibrin (monomer) Fibrin (polymer) Stable fibrin clot
hemophiliacs cant clot
Problems in haemostatis:
insufficient or delayed clotting
intravascular clotting
intravascular clotting
thrombus (clot on vessel wall) can break off and become an embolus which travels through the blood
clot can lodge in the brain (stroke), heart (cardiac infarction), lung (pulmonary embolism), calves (deep vein thrombosis or phlebitis - when people are in a plane sitting)
Disorders of Haemostasis
Inherited Disorders:
Common Haemophilia A- factor VIII and VII:C deficiency – x chromosome defect (mostly men have disease and women are mostly carriers)
Haemophilia B- factor IX deficiency (Christmas disease) – x chromosome defect
Haemophilia C- factor XI deficiency chromosome 4 defect
Von Wildebrand’s disease- defect of platelets, platelet do not aggregate and do not activate factor VIII (proconvertin) – epistaxis (nose bleed symptoms) autosomal inherited by both men and women
Acquired Disorders
- Vitamin K deficiency (clotting factors II- Prothrombin , VII-Proconvertin , IX- Christmas factor , X- Stuart Power Factor)
- Disseminated Intravascular Coagulation (DIC):most often due to infection extra bleeding because of injury- thrombosis or bleeding
- Heparin – inhibits thrombin activation and factor X-
- Coumadin (warfarin) (anticoagulant – thrombosis) – acts to decrease Vit K dependent factors to allow for clotting
- Aspirin – prevents platelets from making PF3
Coagulation Tests
Bleeding Time:
Test analyzes how quickly small blood vessels in your skin close up and stop bleeding.
Test evaluates platelet function, capillary integrity and clotting factors
Method:
• Standard puncture made and blood blotted by filter paper to prevent external clotting.
Platelet count of <50- may prolong the bleeding time
Miekle Modified Ivy Method –Bleeding Time Test (Done by technologists)
- blood pressure cuff on patient forearm inflated to 40 mm Hg
- standard puncture on forearm by template device (2 incisions 5mm wide and 1 mm deep)
- Template device (Simplate or Surgicut) retractable blade
- Start stop watch when puncture made
- Record time at which bleeding stops
NR 1-9 minutes
Critical Value > 12 min
Bleeding Time Test QC
- Do not touch incision when blotting blood droplets
- Record if patient has used aspirin in past 2 weeks (platelet survival is 10 -14 days)
- Proper PPE
- Follow Standard Precautions
Prothrombin Time Test- PT
- Used to monitor oral anticoagulant therapy (Coumadin) - common blood thinner - inactivates factor 7 so patient does not clot easy- too much bleed out not enough too many clots
- Specimen citrated plasma (blue top tube)
- Need Platelet Poor Plasma–Centrifuge 15 min at 3000 rpm, separate plasma and refrigerate; freeze plasma if not tested within 4 hours
- Reagent ( thromboplastin)= (tissue factor III-phospholipid) and CaCl++
- PPP plasma and thromboplastin are incubated for 5 minutes at 37ºC
Incubate no longer than 10mins-why?
• Factor VIII deteriorates
• Reagent evapourates
• Reagent is added to plasma and time to form a clot is measured
• Perform in duplicate: PT result must be within 10%
Tests extrinsic pathway III -> (needs Ca) VII & common pathway-> X ->(needs Ca) V-> II-> I
PT increased by deficiency of factors VII, X, V, II (prothrombin) and I (fibrinogen)
PT increased in liver disease
PT- Manual method: Tilt tube
- mix plasma and reagent
- tilt tubes
- examine visually for clot to form
Automated method
- The instrument monitors tube for change in optical density or electrical resistance
- End point fibrin clot